Journal of the American College of Cardiology

Left ventricular pseudoaneurysm
pp. 557-561(5)
Authors: Frances C.; Romero A.; Grady D.

Biocompatibility aspects of new stent technology - Consensus Conference of the European Society for Biomaterials
pp. 562-571(10)
Authors: Bertrand O.F.; Sipehia R.; Mongrain R.; Rodes J.; Tardif J.-C.; Bilodeau L.; Cote G.; Bourassa M.G.

Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites
pp. 572-576(5)
Authors: Mann T.; Cubeddu G.; Bowen J.; Schneider J.E.; Arrowood M.; Newman W.N.; Zellinger M.J.; Rose G.C.

Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up - fattori predittivi di eventi a breve e lungo termine
pp. 577-583(7)
Authors: De Gregorio J.; Kobayashi Y.; Albiero R.; Reimers B.; Di Mario C.; Finci L.; Colombo A.

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation - A serial intravascular study
pp. 584-589(6)
Authors: Abizaid A.; Kornowski R.; Mintz G.S.; Hong M.K.; Abizaid A.S.; Mehran R.; Pichard A.D.; Kent K.M.; Satler L.F.; Wu H.; Popma J.J.; Leon M.B.

Long-term analysis of conventional coronary balloon angioplasty and an initial ''stent-like'' result - angiographic long term follow up results of a randomized trial
pp. 590-595(6)
Authors: Holmes D.R.; Kip K.E.; Yeh W.; Kelsey S.F.; Detre K.M.; Williams D.O.

A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy - routine cardiac catheterization and angiography is a reasonable approach in most patients
pp. 596-605(10)
Authors: McCullough P.A.; O'Neill W.W.; Graham M.; Stomel R.J.; Rogers F.; David S.; Farhat A.; Kazlauskaite R.; Al-Zagoum M.; Grines C.L.

Mast cell infiltration in acute coronary syndromes: implications for plaque rupture - 72000 dalton gelatinase and fibronectin
pp. 606-612(7)
Authors: Kaartinen M.; van der Wal A.C.; van der Loos C.M.; Piek J.J.; Koch K.T.; Becker A.E.; Kovanen P.T.

Role of different determinants of psychological distress in acute coronary syndromes
pp. 613-619(7)
Authors: Pignalberi C.; Patti G.; Chimenti C.; Pasceri V.; Maseri A.

Intravenous diltiazem in acute myocardial infarction - The Danish Verapamil Infarction Trial II-DAVIT II
pp. 620-628(9)
Authors: Theroux P.; Gregoire J.; Chin C.; Pelletier G.; de Guise P.; Juneau M.

Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty
pp. 629-633(5)
Authors: Liem A.L.; van 't Hof A.W.J.; Hoorntje J.C.A.; de Boer M.-J.; Suryapranata H.; Zijlstra F.

Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience - the importance of early reperfusion
pp. 634-640(7)
Authors: Pfisterer M.; Cox J.L.; Granger C.B.; Brener S.J.; Naylor C.D.; Califf R.M.; van de Werf F.; Stebbins A.L.; Lee K.L.; Topol E.J.; Armstrong P.W.

Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience - Mortality and functional outcomes in the GUSTO-1 trial
pp. 641-647(7)
Authors: Lundergan C.F.; Reiner J.S.; McCarthy W.F.; Coyne K.S.; Califf R.M.; Ross A.M.

Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after q wave myocardial infarction: importance of infarct location adjusted thresholds - non-exercise dependent detection of haemodynamically significant coronary artery stenoses
pp. 648-654(7)
Authors: Schneider C.A.; Voth E.; Gawlich S.; Baer F.M.; Horst M.; Schicha H.; Erdmann E.; Sechtem U.

Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox - analysis of tissue characterizations with comparison to in vitro histological specimens
pp. 655-662(8)
Authors: Pasterkamp G.; Schoneveld A.H.; van der Wal A.C.; Haudenschild C.C.; Clarijs R.J.G.; Becker A.E.; Hillen B.; Borst C.

Plaque Size, Vessel Size and Plaque Vulnerability: Bigger May Not Be Better
pp. 663-664(2)
Author: Shah P.K.

Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin - factors limiting achievement of lipid goals
pp. 665-672(8)
Authors: Brown A.S.; Bakker-Arkema R.G.; Yellen L.; Henley R.W.; Guthrie R.; Campbell C.F.; Koren M.; Woo W.; McLain R.; Black D.M.

Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease - 10-year follow-up of 521 patients
pp. 673-679(7)
Authors: Guerci A.D.; Spadaro L.A.; Goodman K.J.; Lledo-Perez A.; Newstein D.; Lerner G.; Arad Y.

Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women - Monographs on Statistics and Applied Probability
pp. 680-685(6)
Authors: De Bacquer D.; De Backer G.; Kornitzer M.; Myny K.; Doyen Z.; Blackburn H.

Superiority of ''triple'' drug therapy in heart failure: insights from the PROVED and RADIANCE trials - a crossover study
pp. 686-692(7)
Authors: Young J.B.; Gheorghiade M.; Uretsky B.F.; Patterson J.H.; Adams K.F.

Triple Drug Therapy -- What Is Next?
pp. 693-694(2)
Author: Goldstein S.

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials - role of cycle-length windowing
pp. 695-703(9)
Authors: Dries D.L.; Exner D.V.; Gersh B.J.; Domanski M.J.; Waclawiw M.A.; Stevenson L.W.

Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation
pp. 704-710(7)
Authors: Armstrong A.T.; Binkley P.F.; Baker P.B.; Myerowitz P.D.; Leier C.V.

Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men - contribution to alterations of vasomotor tone
pp. 711-716(6)
Authors: Neunteufl T.; Kostner K.; Katzenschlager R.; Zehetgruber M.; Maurer G.; Weidinger F.

Mechanisms of hemolysis after mitral valve repair: assessment by serial echocardiography - anatomic correlations, image orientation, and clinical applications
pp. 717-723(7)
Authors: Yeo T.C.; Freeman W.K.; Schaff H.V.; Orszulak T.A.

Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia
pp. 724-728(5)
Authors: Ellison K.E.; Friedman P.L.; Ganz L.I.; Stevenson W.G.

Expanding Indications for Radiofrequency Catheter Ablation: Ventricular Tachycardia in Association With Right Ventricular Dysplasia?
pp. 729-731(3)
Author: Feld G.K.

Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation - importance of use-depend effects of refractoriness
pp. 732-738(7)
Authors: Chen Y.-J.; Chen S.-A.; Tai C.-T.; Wen Z.-C.; Feng A.-N.; Ding Y.-A.; Chang M.-S.

Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia - The German Dilated CardioMyopathy Study (GDCMS): study design
pp. 739-745(7)
Authors: Grimm W.; Hoffmann J.; Menz V.; Luck K.; Maisch B.

Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent - in vitro and in vivo observations
pp. 746-752(7)
Authors: Cohen J.L.; Cheirif J.; Segar D.S.; Gillam L.D.; Gottdiener J.S.; Hausnerova E.; Bruns D.E.

Mortality in potential arterial switch candidates with transposition of the great arteries - analysis of the risk factors for early and late mortality
pp. 753-757(5)
Authors: Soongswang J.; Adatia I.; Newman C.; Smallhorn J.F.; Williams W.G.; Freedom R.M.

Long-term outcome after the mustard repair for simple transposition of the great arteries - hemodynamic and echocardiographic evaluation
pp. 758-765(8)
Authors: Wilson N.J.; Clarkson P.M.; Barratt-Boyes B.G.; Calder A.L.; Whitlock R.M.L.; Easthope R.N.; Neutze J.M.

Effect of veno-venous ultrafiltration on myocardial performance immediately after cardiac surgery in children - The role of elastase and vasoactive mediators
pp. 766-772(7)
Authors: Rivera E.S.; Kimball T.R.; Bailey W.W.; Witt S.A.; Khoury P.R.; Daniels S.R.

Supraventricular tachycardia in patients with right atrial isomerism - Electrophysiology and pacing
pp. 773-779(7)
Authors: Wu M.-H.; Wang J.-K.; Lin J.-L.; Lai L.-P.; Lue H.-C.; Young M.-L.; Hsieh F.-J.

Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo - A novel approach for prolonged drug delivery after balloon angioplasty
pp. 780-786(7)
Authors: Yamawaki T.; Shimokawa H.; Kozai T.; Miyata K.; Higo T.; Tanaka E.; Egashira K.; Shiraishi T.; Tamai H.; Igaki K.; Takeshita A.

Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging 1
pp. 787-793(7)
Authors: Bremerich J.; Wendland M.F.; Arheden H.; Wyttenbach R.; Gao D.W.; Huberty J.P.; Dae M.W.; Higgins C.B.; Saeed M.

Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes - in vitro validation and pathologic correlation
pp. 794-799(6)
Authors: Mehran R.; Mintz G.S.; Hong M.K.; Tio F.O.; Bramwell O.; Brahimi A.; Kent K.M.; Pichard A.D.; Satler L.F.; Popma J.J.; Leon M.B.

Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes - Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes
pp. 800-807(8)
Authors: Dodge S.M.; Beardslee M.A.; Darrow B.J.; Green K.G.; Beyer E.C.; Saffitz J.E.

Denopamine, a 1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor- production in the heart - direct identification, physiologic regulation, and clinical alterations
pp. 808-815(8)
Authors: Nishio R.; Matsumori A.; Shioi T.; Wang W.; Yamada T.; Ono K.; Sasayama S.

Effects of critical coronary stenosis on global systolic left ventricular function quantified by pressure-volume relations during dobutamine stress in the canine heart - comparative effects of nicorandil, a potential new antianginal agent, and nitroglycerin
pp. 816-826(11)
Authors: Steendijk P.; Baan J.; Van Der Velde E.T.; Baan J.

The ACC professional life survey: career decisions of women and men in cardiology - opportunities and challenges of the '90s [editorial]
pp. 827-835(9)
Authors: Limacher M.C.; Zaher C.A.; Walsh M.N.; Wolf W.J.; Douglas P.S.; Schwartz J.B.; Wright J.S.; Bodycombe D.P.

The Olympics, NBA Playoffs, U.S. Open, the World Cup, and Wimbledon--Points to Ponder
pp. 836-837(2)
Author: Parmley W.W.

President's Page: The ACC and the Cardiovascular Specialty Societies: Working Together to Promote Quality Cardiovascular Care
pp. 838-839(2)
Author: King S.B.I.

Present use of bedside right heart catheterization in patients with cardiac disease1
pp. 840-864(25)
Authors: Mueller H.S.; Chatterjee K.; Davis K.B.; Fifer M.A.; Franklin C.; Greenberg M.A.; Labovitz A.J.; Shah P.K.; Tuman K.J.; Weil M.H.; Weintraub W.S.; Forrester J.S.; Douglas P.S.; Faxon D.P.; Fisher J.D.; Gibbons R.J.; Halperin J.L.; Hochman J.S.; Hutter A.M.; Kaul S.; Weintraub W.S.; Winters W.L.; Wolk M.J.